Inventor · disambiguated record
Jesper Lau
Also filed as: LAU JESPER · LAU JESPER F · LAU JESPER FAERGEMAN
4 granted patents·28 pending applications·192 citations·filing 2000–2023
82Inventor score
Top patents by PatentIndex Score
32 records- 0196USRE45670EAryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2013·Granted Sep 15, 2015·34 cites·22 claims
- 0295US6503949B1Glucagon antagonists/inverse agonistsNORO NORDISK AS·Filed 2000·Granted Jan 7, 2003·67 cites·56 claims
- 0394US6953812B2Glucagon antagonists/inverse agonistsNOVO NORDISK INC·Filed 2003·Granted Oct 11, 2005·56 cites·54 claims
- 0491US6881746B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2003·Granted Apr 19, 2005·35 cites·32 claims
- 0564US2018016319A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 0662US2013244931A1Novel GLP-1 DerivativesNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 0762US2017190757A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 0861US2016271263A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 0960US2007203058A1Novel Glp-1 DerivativesNOVO NORDISK AS·Filed 2004·Application pending·0 cites
- 1060US2017051034A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1158US2005256175A1Novel glucagon antagonists/inverse agonistsLAU JESPER·Filed 2005·Application pending·0 cites
- 1258US2015274801A1Acylated glucagon analoguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1358US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1457US2016002311A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1557US2013143798A1Novel glucagon analoguesLAU JESPER F·Filed 2011·Application pending·0 cites
- 1656US2016108102A1Novel GLP-1 DerivativesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1755US2025304645A1Prodrugs of GLP-1 Polypeptide and Uses ThereofNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 1854US2016347812A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1954US2010317057A1Semi-recombinant preparation of glp-1 analoguesNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2054US2005203108A1Glucagon antagonists/inverse agonistsFiled 2004·Application pending·0 cites
- 2153US2018044394A1Stable, protracted glp-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 2251US2003138416A1Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetesFiled 2002·Application pending·0 cites
- 2350US2003212119A1Novel glucagon receptor antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 2449US2020165313A1Egf(a) analogues, preparation, formulations and uses thereofNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 2548US2004116483A1Glucagon antagonists/inverse agonistsFiled 2003·Application pending·0 cites
- 2647US2025268986A1Glp-1 prodrugs and uses thereofNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 2747US2015210745A1Double-Acylated GLP-1 Derivatives with a LinkerNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2846US2004127560A1Glucagon antagonists/inverse agonistsFiled 2003·Application pending·0 cites
- 2942US2014031278A1Novel Glucagon AnaloguesLAU JESPER F·Filed 2012·Application pending·0 cites
- 3041US2003203946A1Glucagon antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 3138US2015368313A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 3237US2013053310A1Novel glucagon analoguesLAU JESPER F·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jesper Lau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →